Klingenstein Fields & Co’s Amgen AMGN Stock Holding History

Klingenstein Fields & Co’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$402K	Hold	1,142	–	–	0.02%	140
2025 Q4	$374K	Hold	1,142	–	–	0.01%	141
2025 Q3	$322K	Sell	1,142 -57	-5%	-$16.5K	0.01%	145
2025 Q2	$335K	Hold	1,199	–	–	0.01%	141
2025 Q1	$374K	Hold	1,199	–	–	0.02%	129
2024 Q4	$313K	Hold	1,199	–	–	0.01%	143
2024 Q3	$386K	Hold	1,199	–	–	0.02%	136
2024 Q2	$375K	Sell	1,199 -102	-8%	-$30K	0.02%	130
2024 Q1	$370K	Hold	1,301	–	–	0.02%	133
2023 Q4	$375K	Hold	1,301	–	–	0.02%	127
2023 Q3	$350K	Buy	1,301 +111	+9%	+$27.7K	0.02%	127
2023 Q2	$264K	Hold	1,190	–	–	0.01%	149
2023 Q1	$288K	Buy	1,190 +88	+8%	+$21.6K	0.01%	143
2022 Q4	$289K	Hold	1,102	–	–	0.02%	148
2022 Q3	$248K	Sell	1,102 -45	-4%	-$10.9K	0.01%	152
2022 Q2	$279K	Sell	1,147 -46	-4%	-$11.3K	0.01%	145
2022 Q1	$288K	Hold	1,193	–	–	0.01%	157
2021 Q4	$268K	Hold	1,193	–	–	0.01%	162
2021 Q3	$254K	Hold	1,193	–	–	0.01%	174
2021 Q2	$291K	Sell	1,193 -37	-3%	-$9.1K	0.01%	165
2021 Q1	$306K	Buy	1,230 +91	+8%	+$21.7K	0.01%	156
2020 Q4	$262K	Sell	1,139 -200	-15%	-$46.1K	0.01%	158
2020 Q3	$340K	Sell	1,339 -78	-6%	-$19.3K	0.02%	151
2020 Q2	$334K	Buy	+1,417	New	+$323K	0.02%	146
2018 Q1	–	Sell	-2,992	Closed	-$520K	–	220
2017 Q4	$520K	Hold	2,992	–	–	0.02%	156
2017 Q3	$558K	Buy	2,992 +300	+11%	+$53.2K	0.02%	143
2017 Q2	$464K	Hold	2,692	–	–	0.02%	156
2017 Q1	$442K	Sell	2,692 -11	-0.4%	-$1.83K	0.02%	154
2016 Q4	$395K	Buy	2,703 +11	+0.4%	+$1.66K	0.02%	171
2016 Q3	$449K	Hold	2,692	–	–	0.02%	151
2016 Q2	$410K	Hold	2,692	–	–	0.02%	154
2016 Q1	$404K	Hold	2,692	–	–	0.02%	158
2015 Q4	$437K	Hold	2,692	–	–	0.02%	154
2015 Q3	$372K	Hold	2,692	–	–	0.02%	169
2015 Q2	$413K	Sell	2,692 -26,565	-91%	-$4.26M	0.02%	167
2015 Q1	$4.68M	Sell	29,257 -1,280	-4%	-$202K	0.21%	71
2014 Q4	$4.86M	Buy	30,537 +880	+3%	+$137K	0.22%	69
2014 Q3	$4.17M	Sell	29,657 -2,384	-7%	-$311K	0.18%	74
2014 Q2	$3.79M	Buy	32,041 +28,520	+810%	+$3.3M	0.16%	79
2014 Q1	$434K	Buy	3,521 +229	+7%	+$27.8K	0.02%	176
2013 Q4	$376K	Sell	3,292 -250	-7%	-$28.4K	0.01%	236
2013 Q3	$396K	Sell	3,542 -500	-12%	-$54.2K	0.02%	224
2013 Q2	$399K	Buy	+4,042	New	+$419K	0.01%	234

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Klingenstein Fields & Co's AMGN Position: Q1 2026 in Review

Klingenstein Fields & Co held its Amgen (AMGN) position steady in Q1 2026 at 1,142 shares worth $402K. The position accounts for 0.02% of the portfolio, ranked #140.

Klingenstein Fields & Co first reported a position in AMGN in Q2 2013 and has held it in 43 quarters since. The position peaked at $4.86M in Q4 2014. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Klingenstein Fields & Co held 1,142 shares of Amgen worth $402K as of Q1 2026.
Klingenstein Fields & Co left its Amgen share count unchanged in Q1 2026.
Amgen made up 0.02% of Klingenstein Fields & Co's portfolio in Q1 2026, its #140 holding.
Klingenstein Fields & Co first reported a position in Amgen in Q2 2013 and has held it in 43 quarters since.
Klingenstein Fields & Co's Amgen position peaked at $4.86M in Q4 2014.
3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Klingenstein Fields & Co's 13F filing for Q1 2026, filed 13 May 2026.